DORNOCH PHARMACY LIMITED
🌳Matureactive
SC300731 · ltd · incorporated 2006-04-13
Investment thesis
Well-run mature business — low negotiation leverage; premium likely.
Why interesting: Textbook target; clean filings, stable trading.
Why risky: No pressure on seller; any deal likely at full price.
Opportunity decay
hardening · 12-months
Already tight — no obvious softening catalysts on the horizon.
- · Thesis: well-run, low negotiation leverage
🔒Estimated value
—
Upgrade to see
Turnover
—
year to Feb 2025
Net worth
—
book net assets
Opportunity
75/100
Strong
What this business does
Primary activity: Other human health activities
Sector: Human health & social work
Investor take
PursueStrong opportunity: active trading company with strong profile and bankable structure.
Opportunity 75/100 (strong), bankability 77/100. Strong seller-intent signal (68/100, director aged 47). Share purchase looks the cleaner deal structure. Biggest value-creation lever: Consolidate lender relationships. 3 distinct lenders creates friction — refinance into single-lender structure for cleaner diligence. Most likely exit: strategic trade sale (73/100).
🏦
Refinance opportunity
3 live charges · 3 lenders · oldest 19.4y
35/100
too messy
Refinance path is blocked by complexity. Rethink structure or expect bespoke, expensive terms.
- · Oldest live charge is 19.4 years old — likely at or near maturity.
- · 3 lenders named — inter-creditor friction likely.
- · Legal-friction score 25/100 — workable, but lender will want more DD.
Data confidence
Overall: high (80/100)Strong data coverage across all sections. AI outputs should be trusted with minimal caveats.
Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
3 charges (3/3 with lender, 3/3 with type)
90
Directors & officers
3 officers (3 active, 3 linked, 2 with DOB)
83
Ownership & PSC
2 active PSC(s) of 2 total, 2 with control declared
90
Director network
3 connected companies via shared directors
54
Filing history
65 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
75/100Strong
PassWatchWorth a lookStrongExceptional
Solid opportunity signal. Worth a dedicated memo and management meeting.
Business quality
70
Active, clean filings, stable charge profile.
Acquirability
65
Some acquirability indicators.
Risk profile
77
Few red flags.
Signal strength
100
Good data coverage for analysis.
Key financials
2 years extracted from filed iXBRL accountsCash
—
Net Worth
—
Current Assets
—
Current Liabilities
—
Hover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · FRS 102| Metric | 2025-02-28 | 2024-02-28 |
|---|---|---|
| Average employees | 9 | 900 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
🔒Filing-note intelligence
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
Last 30 days
0
filings
Last 90 days
0
filings
Last 180 days
1
filing
- • 1 accounts
Counts from Companies House filing history.
Corporate timeline (27 events)Click to expand
- 2025-11-25📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2024-10-04📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-08-08📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-07-19📄capital-name-of-class-of-sharescapital · SH08
- 2023-07-19📄capital-name-of-class-of-sharescapital · SH08
- 2023-04-27📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2023-04-27📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2023-04-27📄change-person-director-company-with-change-dateofficers · CH01
- 2023-04-27📄change-person-director-company-with-change-dateofficers · CH01
- 2022-11-28📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2022-02-28📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2021-01-22📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2020-02-13📄mortgage-satisfy-charge-fullmortgage · MR04
- 2020-02-13🔓Charge satisfied #2
- 2020-02-12📄mortgage-satisfy-charge-fullmortgage · MR04
- 2020-02-12🔓Charge satisfied #3
- 2019-11-07📄mortgage-satisfy-charge-fullmortgage · MR04
- 2019-11-07🔓Charge satisfied #1
- 2019-08-08📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2018-11-08📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2011-11-09🔒Charge registered #3Lender: Bank of Scotland PLC
- 2006-12-07🔒Charge registered #1Lender: Aah Pharmaceuticals LTD and Another
- 2006-12-04🔒Charge registered #2Lender: The Governor and Company of the Bank of Scotland
- 2006-04-13🏢Company incorporatedAs DORNOCH PHARMACY LIMITED
- 2006-04-13➕DIXON, Lucy Anne appointedsecretary
- 2006-04-13➕DIXON, Gareth George Irwin appointeddirector
- 2006-04-13➕DIXON, Lucy Anne appointeddirector
Owner dependency
76/100
High — earn-out structure requiredMaterial founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
FACTORS
- +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
- +Long-tenure founder: Senior director has been in place 20 years — deep operational knowledge concentrated in one person.
- +Family involvement: Multiple officers share a surname — likely family business, which concentrates governance.
Succession & seller-readiness
66/100
Strong succession signalMultiple signals suggest succession is on the horizon. Candidate for proactive outreach.
SIGNALS
- secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
- primary20+ year tenure: Director in role 20 years. Very long tenure is a classic succession signal.
- secondaryStable-but-static management: Company is 20 years old and no new directors in the last 3 years — succession not yet being planned internally.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
1 med ·Charge satisfaction-then-recreation pattern
mediumMultiple instances where a charge was satisfied and a new charge created within 6 months. Suggests active refinancing cycle.
Shareholders & ownership
2 active beneficial owners| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mr Gareth George Irwin Dixon Individual · British · DOB 03/1979 · age 47 | 25–50% | — | 25-50% shares | 13/04/2016 |
Mrs Lucy Anne Dixon Individual · British · DOB 10/1980 · age 46 | 25–50% | — | 25-50% shares | 13/04/2016 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
🔒Co-director network graph
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Healthcare & medical · IV postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| CAROLTON CARE LTD.→ SC269889 · est 2004 · no financials extracted | — | — | — | — | 21y | — | — |
| COUNSELLING PSYCHOLOGY SCOTLAND LTD→ SC787138 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| CRAIG R. CAMPBELL OPTICAL LTD→ SC700680 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| CRIMOND CARE LIMITED→ SC647478 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| DR ABBASI GROUP LTD→ SC883403 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| EAR WORKS SERVICES LTD→ SC808059 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| EILEAN DUBH HOME CARE LIMITED→ SC676748 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| ELEVATE FITNESS KR LTD→ SC838381 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| ELIXIR MEDICAL AESTHETICS LTD→ SC842756 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| ESTHETIQUE (INVERNESS) LIMITED→ SC601515 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| EWEN RIDDICK LOCUMS LTD→ SC805880 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| FAIRBURN CARE HOME LIMITED→ SC850016 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions
6 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →🔒Advanced scoring suite
Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Statusactive
Typeltd
Incorporated2006-04-13
Jurisdictionscotland
Primary SIC86900 — Other human health activities
Registered office
High Street
Dornoch
IV25 3SH
Filing status
Accounts
Next due: 2026-11-30
Last made up to: 2025-02-28
Confirmation statement
Next due: 2026-05-10
Last: 2025-04-26
Officers (3 active · 0 resigned)
Active
DIXON, Gareth George Irwin→
Activedirector · ~47y · appointed 2006-04-13
View their other companies + combined net worth →
DIXON, Lucy Anne→
Activedirector · ~46y · appointed 2006-04-13
View their other companies + combined net worth →
Click a director name to see their full track record across all companies.
Mortgages & charges
3
Total charges
0
Outstanding
0
Active lenders
Status:Lender:3 of 3 shown
| Type | Properties | |||||
|---|---|---|---|---|---|---|
| satisfied | Lloyds Banking Group Bank of Scotland PLC | Standard security | 1 property | 09/11/2011 | 12/02/2020 | |
| satisfied | Aah Pharmaceuticals and Another Aah Pharmaceuticals LTD and Another | Bond & floating charge | 1 property | 07/12/2006 | 07/11/2019 | |
| satisfied | Lloyds Banking Group The Governor and Company of the Bank of Scotland | Floating charge | 1 property | 04/12/2006 | 13/02/2020 |
Recent filings (65 total)
accounts-with-accounts-type-total-exemption-full
accounts · AA
2025-11-25
confirmation-statement-with-updates
confirmation-statement · CS01
2025-05-05
accounts-with-accounts-type-total-exemption-full
accounts · AA
2024-10-04
confirmation-statement-with-updates
confirmation-statement · CS01
2024-04-29
accounts-with-accounts-type-total-exemption-full
accounts · AA
2023-08-08
capital-name-of-class-of-shares
capital · SH08
2023-07-19
capital-name-of-class-of-shares
capital · SH08
2023-07-19
confirmation-statement-with-updates
confirmation-statement · CS01
2023-04-27
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2023-04-27
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2023-04-27
change-person-director-company-with-change-date
officers · CH01
2023-04-27
change-person-director-company-with-change-date
officers · CH01
2023-04-27
accounts-with-accounts-type-total-exemption-full
accounts · AA
2022-11-28
confirmation-statement-with-no-updates
confirmation-statement · CS01
2022-04-29
accounts-with-accounts-type-total-exemption-full
accounts · AA
2022-02-28